LadRx Corporation (LADX)

USD 1.61

(-2.42%)

Total Debt Summary of LadRx Corporation

  • LadRx Corporation's latest annual total debt in 2023 was 33.6 Thousand USD , down -85.36% from previous year.
  • LadRx Corporation's latest quarterly total debt in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • LadRx Corporation reported annual total debt of 229.6 Thousand USD in 2022, down -44.7% from previous year.
  • LadRx Corporation reported annual total debt of 415.2 Thousand USD in 2021, down -30.37% from previous year.
  • LadRx Corporation reported quarterly total debt of - USD for 2024 Q2, down 0.0% from previous quarter.
  • LadRx Corporation reported quarterly total debt of 33.6 Thousand USD for 2023 FY, down -85.36% from previous quarter.

Annual Total Debt Chart of LadRx Corporation (2023 - 1989)

Historical Annual Total Debt of LadRx Corporation (2023 - 1989)

Year Total Debt Total Debt Growth
2023 33.6 Thousand USD -85.36%
2022 229.6 Thousand USD -44.7%
2021 415.2 Thousand USD -30.37%
2020 596.3 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD -100.0%
2017 10.59 Million USD -55.77%
2016 23.96 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD -100.0%
1999 650 Thousand USD 0.0%
1998 - USD -100.0%
1997 2 Million USD 0.0%
1996 - USD 0.0%
1995 - USD 0.0%
1994 - USD 0.0%
1993 - USD 0.0%
1992 - USD 0.0%
1991 - USD -100.0%
1990 200 Thousand USD -92.86%
1989 2.8 Million USD 0.0%

Peer Total Debt Comparison of LadRx Corporation

Name Total Debt Total Debt Difference
Eiger BioPharmaceuticals, Inc. 41.2 Million USD 99.918%
Nanobac Pharmaceuticals, Incorporated 4.12 Million USD 99.185%
SQZ Biotechnologies Company 27.47 Million USD 99.878%
Evofem Biosciences, Inc. 43.37 Million USD 99.923%
Santhera Pharmaceuticals Holding AG 29.76 Million USD 99.887%
Mesoblast Limited 118.7 Million USD 99.972%
Propanc Biopharma, Inc. 948.27 Thousand USD 96.456%
Genus plc 233.1 Million USD 99.986%
VioQuest Pharmaceuticals, Inc. 2.93 Million USD 98.853%
CNBX Pharmaceuticals Inc. 1.34 Million USD 97.499%
Marizyme, Inc. 18.71 Million USD 99.82%
ContraFect Corporation 2.88 Million USD 98.834%
Nymox Pharmaceutical Corporation 750 Thousand USD 95.519%
PsyBio Therapeutics Corp. 135.48 Thousand USD 75.196%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.44 Million USD 97.676%
Intellipharmaceutics International Inc. 2.32 Million USD 98.555%
AXIM Biotechnologies, Inc. 5.65 Million USD 99.406%
MultiCell Technologies, Inc. 202.58 USD -16489.002%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 57.48 Million USD 99.942%
EV Biologics, Inc. 1.49 Million USD 97.752%
Q BioMed Inc. 4.1 Million USD 99.182%
Emmaus Life Sciences, Inc. 33.1 Million USD 99.898%
Neon Bloom, Inc. 630.07 Thousand USD 94.666%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 97.264%
Biomind Labs Inc. 735.54 Thousand USD 95.431%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 171.54 Million USD 99.98%
Oncotelic Therapeutics, Inc. 12.99 Million USD 99.741%
Skye Bioscience, Inc. 4.61 Million USD 99.272%
Therapeutic Solutions International, Inc. 888.06 Thousand USD 96.216%
THC Farmaceuticals, Inc. 141.51 Thousand USD 76.253%
Arch Therapeutics, Inc. 5.87 Million USD 99.428%
IMV Inc. 28.88 Million USD 99.884%
Acro Biomedical Co., Ltd. 25.71 Thousand USD -30.666%
Curative Biotechnology, Inc. 2.25 Million USD 98.512%
GB Sciences, Inc. 1.75 Million USD 98.09%
Alpha Cognition Inc. 1.22 Million USD 97.246%
HST Global, Inc. 98.31 Thousand USD 65.819%
CSL Limited 12.18 Billion USD 100.0%
Halberd Corporation 150 Thousand USD 77.596%
Enzolytics Inc. 996.33 Thousand USD 96.627%
Resverlogix Corp. 6.49 Million USD 99.482%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 477.5 Thousand USD 92.962%
Nuo Therapeutics, Inc. 255.59 Thousand USD 86.852%
argenx SE 20 Million USD 99.832%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 45.56 Million USD 99.926%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. 2.7 Million USD 98.759%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 10.22 Thousand USD -228.665%
Genscript Biotech Corporation 417.73 Million USD 99.992%
Ember Therapeutics, Inc. 200.61 Thousand USD 83.249%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 2.39 Million USD 98.598%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 85.344%
American Oriental Bioengineering, Inc. 67.64 Million USD 99.95%
Provectus Biopharmaceuticals, Inc. 3.02 Million USD 98.889%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation 359.71 Thousand USD 90.657%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 20.32 Million USD 99.835%
Cotinga Pharmaceuticals Inc. 148.65 Thousand USD 77.393%
BioStem Technologies, Inc. 4.71 Million USD 99.287%
ONE Bio Corp. 19.71 Million USD 99.83%
Reve Technologies, Inc. 250.18 Thousand USD 86.567%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. 248.72 Thousand USD 86.488%
Agentix Corp. 50 Thousand USD 32.788%
Cell Source, Inc. 9.25 Million USD 99.637%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 756.2 Thousand USD 95.556%
Regen BioPharma, Inc. 756.2 Thousand USD 95.556%
NovAccess Global Inc. 2.19 Million USD 98.472%
Endonovo Therapeutics, Inc. 7.07 Million USD 99.525%
Itoco Inc. 228.37 Thousand USD 85.285%
Rasna Therapeutics, Inc. 210.97 Thousand USD 84.071%
Pathfinder Cell Therapy, Inc. 4.98 Million USD 99.326%
Kadimastem Ltd 891.22 Thousand USD 96.229%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. 401.84 Thousand USD 91.637%
CytoDyn Inc. 30.07 Million USD 99.888%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. 484.28 Thousand USD 93.061%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 351.84 Thousand USD 90.449%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 99.57%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. 122.5 Thousand USD 72.567%
Rebus Holdings, Inc. 310 Thousand USD 89.159%
ImmunoCellular Therapeutics, Ltd. 4.73 Million USD 99.29%
International Stem Cell Corporation 4.17 Million USD 99.196%
Bioxytran, Inc. 1.92 Million USD 98.254%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. 62.41 Thousand USD 46.155%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. 2.18 Million USD 98.459%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.31 Million USD 99.596%
Adhera Therapeutics, Inc. 8.58 Million USD 99.609%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. 1.55 Million USD 97.84%
Innovation Pharmaceuticals Inc. 268 Thousand USD 87.46%
Neutra Corp. 54.15 Thousand USD 37.946%
Windtree Therapeutics, Inc. 1.83 Million USD 98.164%
PureTech Health plc 25.51 Million USD 99.868%
Coeptis Therapeutics, Inc. 1.22 Million USD 97.255%
IXICO plc 472.02 Thousand USD 92.88%
IntelGenx Technologies Corp. 15.5 Million USD 99.783%
Gelesis Holdings, Inc. 62.26 Million USD 99.946%
CSL Limited 12.18 Billion USD 100.0%
Cellectis S.A. 92.77 Million USD 99.964%